Cost Of New Drug Development Pushed To $2.6 Bil. By High Failure Rate – Study

The Tufts Centers for the Study of Drug Development updates its often-quoted drug development cost benchmark in a study released Nov. 18.

More from Clinical Trials

More from R&D